These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 18056195
21. Novel agents that potentially inhibit irinotecan-induced diarrhea. Yang X, Hu Z, Chan SY, Chan E, Goh BC, Duan W, Zhou S. Curr Med Chem; 2005; 12(11):1343-58. PubMed ID: 15975002 [Abstract] [Full Text] [Related]
22. Excretion into gastrointestinal tract of irinotecan lactone and carboxylate forms and their pharmacodynamics in rodents. Arimori K, Kuroki N, Kumamoto A, Tanoue N, Nakano M, Kumazawa E, Tohgo A, Kikuchi M. Pharm Res; 2001 Jun; 18(6):814-22. PubMed ID: 11474786 [Abstract] [Full Text] [Related]
24. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Rao CV, Hirose Y, Indranie C, Reddy BS. Cancer Res; 2001 Mar 01; 61(5):1927-33. PubMed ID: 11280748 [Abstract] [Full Text] [Related]
30. Effect of genistein, a natural soy isoflavone, on the pharmacokinetics and intestinal toxicity of irinotecan hydrochloride in rats. Yokooji T, Kawabe Y, Mori N, Murakami T. J Pharm Pharmacol; 2013 Feb 01; 65(2):280-91. PubMed ID: 23278696 [Abstract] [Full Text] [Related]
31. A multicenter, phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma. Rothenberg ML, Cox JV, DeVore RF, Hainsworth JD, Pazdur R, Rivkin SE, Macdonald JS, Geyer CE, Sandbach J, Wolf DL, Mohrland JS, Elfring GL, Miller LL, Von Hoff DD. Cancer; 1999 Feb 15; 85(4):786-95. PubMed ID: 10091755 [Abstract] [Full Text] [Related]
32. The number of intestinal bacteria is not critical for the enhancement of antitumor activity and reduction of intestinal toxicity of irinotecan by the Chinese herbal medicine PHY906 (KD018). Lam W, Jiang Z, Guan F, Hu R, Liu SH, Chu E, Cheng YC. BMC Complement Altern Med; 2014 Dec 15; 14():490. PubMed ID: 25510341 [Abstract] [Full Text] [Related]
33. Prevention of irinotecan induced diarrhea by probiotics: A randomized double blind, placebo controlled pilot study. Mego M, Chovanec J, Vochyanova-Andrezalova I, Konkolovsky P, Mikulova M, Reckova M, Miskovska V, Bystricky B, Beniak J, Medvecova L, Lagin A, Svetlovska D, Spanik S, Zajac V, Mardiak J, Drgona L. Complement Ther Med; 2015 Jun 15; 23(3):356-62. PubMed ID: 26051570 [Abstract] [Full Text] [Related]
35. Effect of amount and types of dietary fat on intestinal bacterial 7 alpha-dehydroxylase and phosphatidylinositol-specific phospholipase C and colonic mucosal diacylglycerol kinase and PKC activities during stages of colon tumor promotion. Reddy BS, Simi B, Patel N, Aliaga C, Rao CV. Cancer Res; 1996 May 15; 56(10):2314-20. PubMed ID: 8625306 [Abstract] [Full Text] [Related]
38. Traditional Chinese medicine Gegen Qinlian decoction ameliorates irinotecan chemotherapy-induced gut toxicity in mice. Wu Y, Wang D, Yang X, Fu C, Zou L, Zhang J. Biomed Pharmacother; 2019 Jan 15; 109():2252-2261. PubMed ID: 30551482 [Abstract] [Full Text] [Related]
39. The modulation of irinotecan-induced diarrhoea and pharmacokinetics by three different classes of pharmacologic agents. Chowbay B, Sharma A, Zhou QY, Cheung YB, Lee EJ. Oncol Rep; 2003 Jan 15; 10(3):745-51. PubMed ID: 12684653 [Abstract] [Full Text] [Related]